NZ523772A - Vaccines for equine herpesvirus type-1: viruses harboring mutations within the immediate early gene - Google Patents

Vaccines for equine herpesvirus type-1: viruses harboring mutations within the immediate early gene

Info

Publication number
NZ523772A
NZ523772A NZ523772A NZ52377201A NZ523772A NZ 523772 A NZ523772 A NZ 523772A NZ 523772 A NZ523772 A NZ 523772A NZ 52377201 A NZ52377201 A NZ 52377201A NZ 523772 A NZ523772 A NZ 523772A
Authority
NZ
New Zealand
Prior art keywords
ehv
isolate
virus
gene
mutation
Prior art date
Application number
NZ523772A
Other languages
English (en)
Inventor
Dennis J O'callaghan
Original Assignee
Res Corp Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Corp Technologies Inc filed Critical Res Corp Technologies Inc
Publication of NZ523772A publication Critical patent/NZ523772A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16761—Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NZ523772A 2000-07-27 2001-07-27 Vaccines for equine herpesvirus type-1: viruses harboring mutations within the immediate early gene NZ523772A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62674800A 2000-07-27 2000-07-27
PCT/US2001/023612 WO2002009750A2 (fr) 2000-07-27 2001-07-27 Vaccins pour le type 1 du virus herpetique equin: mutations hebergeant les virus dans le gene precoce immediat

Publications (1)

Publication Number Publication Date
NZ523772A true NZ523772A (en) 2004-06-25

Family

ID=24511676

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ523772A NZ523772A (en) 2000-07-27 2001-07-27 Vaccines for equine herpesvirus type-1: viruses harboring mutations within the immediate early gene

Country Status (9)

Country Link
EP (1) EP1317481A2 (fr)
JP (1) JP2004512826A (fr)
AR (1) AR031599A1 (fr)
AU (1) AU2001282997A1 (fr)
CA (1) CA2417340A1 (fr)
DE (1) DE01961753T1 (fr)
MX (1) MXPA03000823A (fr)
NZ (1) NZ523772A (fr)
WO (1) WO2002009750A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1129722A1 (fr) 2000-02-17 2001-09-05 Boehringer Ingelheim Vetmedica Gmbh Mutants gM-négatifs de l'EHV
AR040601A1 (es) 2002-07-19 2005-04-13 Boehringer Ingelheim Vetmed Mutantes ehv negativos de gm sin elementos heterologos
AU2003251356A1 (en) * 2002-07-26 2004-02-16 Animal Health Trust Viral marker
SG11201405847SA (en) * 2012-03-20 2014-10-30 Merial Inc Recombinant equine herpesvirus-1 vaccine containing mutated glycoprotein c and uses thereof
CN108315487B (zh) * 2018-04-16 2021-06-22 福建省农业科学院生物技术研究所 一种检测鳗鲡疱疹病毒的引物组、试剂盒及其应用
CN110885794A (zh) * 2019-10-30 2020-03-17 新疆农业大学 一种马疱疹病毒1型及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5292653A (en) * 1989-09-27 1994-03-08 Novagene, Inc. Equine herpesvirus 1 tk mutants
EP0668355B1 (fr) * 1993-12-20 1999-04-07 Akzo Nobel N.V. Vaccin pour protéger des chevaux contre des infections du virus de l'herpes équin

Also Published As

Publication number Publication date
AR031599A1 (es) 2003-09-24
WO2002009750A2 (fr) 2002-02-07
EP1317481A2 (fr) 2003-06-11
MXPA03000823A (es) 2003-09-10
AU2001282997A1 (en) 2002-02-13
WO2002009750A3 (fr) 2003-03-27
JP2004512826A (ja) 2004-04-30
CA2417340A1 (fr) 2002-02-07
DE01961753T1 (de) 2004-03-11

Similar Documents

Publication Publication Date Title
Tengelsen et al. Herpes simplex virus type 1 DNA cleavage and encapsidation require the product of the UL28 gene: isolation and characterization of two UL28 deletion mutants
US8986707B2 (en) gM-negative EHV-mutants without heterologous elements
JP6952112B2 (ja) 新規なｅｈｖ挿入部位ｏｒｆ７０
Watanabe et al. Properties of a herpes simplex virus multiple immediate-early gene-deleted recombinant as a vaccine vector
JP5469444B2 (ja) 異種要素が無いｇＭ−ネガティブＥＨＶ−変異体
EP0606437A1 (fr) Vaccin d'herpesvirus vivant non excretable
US5837261A (en) Viral vaccines
NZ523772A (en) Vaccines for equine herpesvirus type-1: viruses harboring mutations within the immediate early gene
JP5177927B2 (ja) ｇＭ陰性ＥＨＶ変異体
SK10702001A3 (sk) Vakcína proti BHV-1 obsahujúca vírus s deletovaným génom
AU2001248313A1 (en) gM-negative EHV-mutants
US7374768B1 (en) Viral vaccines
NZ538251A (en) gM-negative EHV-mutants without heterologous elements

Legal Events

Date Code Title Description
PSEA Patent sealed